NewsBenzinga美国食品和药物管理局(FDA)解除对Filana Therapeutics的临床暂停,以启动计划中的2a期试验,针对患有结节性硬化复杂相关癫痫的参与者的新药申请。 美国食品和药物管理局(FDA)解除对Filana Therapeutics的临床暂停,以启动计划中的2a期试验,针对患有结节性硬化复杂相关癫痫的参与者的新药申请。 Benzinga 2026.09.22 12:06 (GMT+0) Open on Benzinga Other news Motorola Solutions Hikes Quarterly Dividend From $1.21 To $1.34 Per Share These 9 Congress Members Could Have Increased Interest in Nvidia’s Q3 Earnings as 2026 Shareholders $100 Invested In Cigna Group 20 Years Ago Would Be Worth This Much Today Needham Maintains Buy on FuboTV, Lowers Price Target to $10 BTIG Reiterates Buy on Amer Sports, Maintains $42 Price Target If You Invested $1000 In Ulta Beauty Stock 15 Years Ago, You Would Have This Much Today